Product Information

ROSUVASTATIN CALCIUM 40 MG TAB is a generic product labeled by Accord Healthcare Inc., priced at $0.0621 per EA under NDC 16729028717. Its NADAC has been published 496 times since Nov 23, 2016.

FDA first approved this application on Oct 31, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ROSUVASTATIN CALCIUM 40 MG TAB

Rosuvastatin
$0.0621per EA

Strength

40 mg/1

NDC

16729028717

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

5/20/2026

Active Ingredients

ROSUVASTATIN CALCIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA206434

FDA Approved

10/31/2016

TE Code

AB

On Market Since

10/31/2016

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for ROSUVASTATIN CALCIUM 40 MG TAB has been published 496 times since Nov 23, 2016, and over the history we have for it it has declined 78.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0621 per EA
All-time high$0.3066 (Jan 11, 2017)
All-time low$0.0591 (Apr 22, 2026)
52-week high$0.0754
52-week low$0.0591
Median price$0.1305
Average price$0.1323
Largest weekly change+25.6% (Aug 21, 2024)
Weeks tracked496
Tracking sinceNov 23, 2016

Price History

1W

N/A

1M

N/A

3M

N/A

6M

-0.4%

1Y

-17.6%

3Y

-45.4%

5Y

-51.9%

All

-78.0%

Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ROSUVASTATIN CALCIUM 40 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for ROSUVASTATIN CALCIUM 40 MG TAB, manufactured by Accord Healthcare Inc., is $0.0621 per EA (NDC 16729028717), effective May 20, 2026.

How has the price of ROSUVASTATIN CALCIUM 40 MG TAB changed over time?

Over the history we have for it, the NADAC for ROSUVASTATIN CALCIUM 40 MG TAB has declined 78.0%. It has been tracked across 496 weekly CMS publications since Nov 23, 2016.

What are the highest and lowest recorded NADAC prices for ROSUVASTATIN CALCIUM 40 MG TAB?

Since Nov 23, 2016, the NADAC for ROSUVASTATIN CALCIUM 40 MG TAB has ranged from a low of $0.0591 (Apr 22, 2026) to a high of $0.3066 (Jan 11, 2017), with a median of $0.1305 per EA.

Are there cheaper alternatives to ROSUVASTATIN CALCIUM 40 MG TAB?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ROSUVASTATIN CALCIUM 40 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures ROSUVASTATIN CALCIUM 40 MG TAB?

ROSUVASTATIN CALCIUM 40 MG TAB (NDC 16729028717) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.